McKesson Corporation $MCK Shares Purchased by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC boosted its holdings in McKesson Corporation (NYSE:MCK) by 26.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,506 shares of the company’s stock after acquiring an additional 522 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in McKesson were worth $2,508,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of MCK. Nvwm LLC boosted its position in shares of McKesson by 933.3% during the 3rd quarter. Nvwm LLC now owns 31 shares of the company’s stock worth $26,000 after purchasing an additional 28 shares in the last quarter. Delos Wealth Advisors LLC purchased a new position in shares of McKesson in the 2nd quarter valued at about $27,000. Trellis Wealth Advisors LLC purchased a new position in shares of McKesson in the 3rd quarter valued at about $32,000. GK Wealth Management LLC acquired a new stake in shares of McKesson in the third quarter valued at about $38,000. Finally, Curry Webb Wealth Management LLC acquired a new stake in shares of McKesson in the third quarter valued at about $38,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Key McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

McKesson Stock Performance

Shares of NYSE:MCK opened at $1,060.79 on Friday. The business’s fifty day moving average price is $938.13 and its two-hundred day moving average price is $868.12. The stock has a market cap of $123.68 billion, a PE ratio of 27.28, a price-to-earnings-growth ratio of 1.99 and a beta of 0.27. McKesson Corporation has a one year low of $723.68 and a one year high of $1,121.50.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.72 by $0.96. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The business had revenue of $110.96 billion for the quarter, compared to the consensus estimate of $109.90 billion. During the same period in the prior year, the business earned $9.86 earnings per share. The business’s revenue was up 7.5% on a year-over-year basis. As a group, equities research analysts predict that McKesson Corporation will post 45.26 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s payout ratio is 9.67%.

Insider Transactions at McKesson

In other news, EVP Francisco Fraga sold 650 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president owned 4,414 shares of the company’s stock, valued at $4,868,465.44. The trade was a 12.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares in the company, valued at $464,445.45. The trade was a 17.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,462 shares of company stock worth $2,511,106 over the last ninety days. 0.06% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

MCK has been the topic of several recent analyst reports. Leerink Partners upped their target price on shares of McKesson from $1,070.00 to $1,200.00 and gave the stock an “outperform” rating in a research report on Thursday. Mizuho lifted their price target on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research report on Tuesday, October 20th. Bank of America upped their price target on McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. UBS Group raised their price objective on McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Royal Bank Of Canada raised their price objective on McKesson from $845.00 to $965.00 and gave the company a “sector perform” rating in a research note on Thursday. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $1,026.18.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.